Your trusted source for investing success

Tag: AveXis

5 February IPOs on the NASDAQ

5 February IPOs on the NASDAQ

This month, investors can expect some new blood to enter the life science market, with five companies — Editas Medicine, BeiGene, Protestasis Therapeutics, AveXis, Cancer Prevention Pharmaceuticals— listing on the NASDAQ.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
4 Gene Therapy Stocks to Watch in 2017